Constructing an immune-related prognostic model and exploring the function of HMGB3, TNFSF4, and CORO2A in breast cancer
This prognostic model reliably assessed risk for BC patients, providing critical guidance for precision oncology protocols and dynamic surveillance of disease progression.
Authors
- Yaqin Zhao (ORCID: https://orcid.org/0000-0003-0275-7800)
- Meng Tang (ORCID: https://orcid.org/0000-0003-0561-2906)
- Tingting Huang (ORCID: https://orcid.org/0000-0002-0212-9364)
- Rui Pan (ORCID: https://orcid.org/0000-0002-1801-2080)
- Chi Chiu Wang (ORCID: https://orcid.org/0000-0002-3928-7278)
- Wei Zhang (ORCID: https://orcid.org/0000-0002-6968-6974)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Sichuan Cancer Hospital (CN)
- Shanghai Clinical Research Center (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/tcr-2025-1049
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.00